Pachyonychia Congenita: 5 Subtypes, Symptoms, And Treatments

Pachyonychia congenita (PC) is a group of rare, inherited disorders of keratinisation characterised by

thickened skin on the palms and soles (palmoplantar keratoderma)

,

hypertrophic nail dystrophy

, and

white patches in mucous membranes (leukokeratosis)

. The condition profoundly impacts quality of life due to severe pain, particularly on weight-bearing areas of the feet.

Introduction

Pachyonychia congenita involves defects in the process by which keratin—a tough protein—is formed and deposited in the skin’s outermost layer (epidermis). Mutations in specific keratin genes disrupt the structural integrity of skin cells, leading to fragility under mechanical stress. Normal activities like walking cause cell breakdown, resulting in blisters, calluses, and nail abnormalities. PC is classified into subtypes based on the affected gene, influencing the predominant clinical features.

Demographics

PC affects approximately 1 in 150,000 to 1 in 1,000,000 individuals worldwide, with no strong racial or geographic predilection. It manifests at birth or early childhood, often noticed when infants begin weight-bearing. Females and males are equally affected due to autosomal dominant inheritance. Natal teeth occur more frequently in PC-17 subtype.

• Prevalence: Rare; exact figures vary but consistently reported as under 1 per 100,000.
• Age of onset: Nails dystrophic by 1 year; plantar keratoderma with walking (1-2 years).
• Sex distribution: Equal.

Causes

PC results from

autosomal dominant mutations

in five keratin genes: KRT6A (PC-6a), KRT6B (PC-6b), KRT6C (PC-6c), KRT16 (PC-16), and KRT17 (PC-17). These encode high-sulfur keratins expressed in epithelial tissues like nails, palms, soles, oral mucosa, hair follicles, and glands. Mutant keratins form unstable filaments, rendering cells susceptible to trauma-induced rupture.

Subtype	Gene	Key Features
PC-6a	KRT6A	Focal plantar keratoderma, oral leukokeratosis, cysts
PC-6b	KRT6B	Palmoplantar keratoderma, oral involvement
PC-6c	KRT6C	Mild skin/nail changes, focal hyperkeratosis
PC-16	KRT16	Palmoplantar pain, nail dystrophy, follicular hyperkeratosis
PC-17	KRT17	Natal teeth, oral leukokeratosis, steatocystomas

De novo mutations account for ~30% of cases; penetrance is high (>95%), but expressivity varies.

Clinical Features

The hallmark triad is

hypertrophic nail dystrophy

,

painful palmoplantar keratoderma

, and

mucosal leukokeratosis

. Plantar pain is debilitating, often requiring mobility aids.

Nail Dystrophy

Toenails show wedge-shaped thickening, subungual hyperkeratosis, and yellow-brown discoloration, starting infancy. Fingernails less severely affected. Upward nail plate angle >10° is characteristic.

Palmoplantar Keratoderma

Firm, painful calluses on pressure points (heels, balls of feet) form with ambulation. Blisters beneath cause excruciating pain; hyperhidrosis worsens friction. Hands show milder hyperkeratosis.

Oral Leukokeratosis

White plaques on tongue, gingivae, buccal mucosa from birth/infancy. Benign, thickens with age; PC-6a most severe.

Cysts

Steatocystomas (PC-17), vellus hair cysts (PC-6a), hidrocystomas, odontogenic cysts. Appear post-puberty.

Other Features

• Follicular hyperkeratosis: On legs, arms (PC-16).
• Hyperhidrosis: Palms/soles (~50%).
• Natal/prenatal teeth: PC-17 (~50%).
• Rare: Angular cheilitis, hoarse voice, first bite syndrome (jaw pain on eating).

Classification

Originally Jadassohn-Lewandowsky (PC-1: nails/skin/mucosa) vs. Jackson-Lawler (PC-2: cysts/natal teeth). Now gene-based subtypes (PC-6a/b/c, PC-16/17) better reflect phenotypes.

Diagnosis

Suspected clinically: nail thickening + plantar keratoderma/pain by age 10 in 97%. Confirmed by

genetic testing

identifying pathogenic variant in KRT6A/B/C/16/17. Skin biopsy shows compact hyperkeratosis, acanthosis; electron microscopy reveals keratin aggregates (research use).

• 97% sensitivity: Triad by childhood.

Differential Diagnoses

Condition	Distinguishing Features
Unna-Thost PPK	Diffuse non-painful keratoderma; no nail/mucosal changes
Vörner PPK	Painful but no cysts/nails
Onychogryphosis	Acquired claw-like nails; no skin changes
Candida onychomycosis	Paronychia without PPK; KOH positive
Steatocystoma multiplex	Cysts without nails/PPK

Rule out infection if isolated nail changes.

Treatment

No cure;

symptomatic management

focuses on pain relief, preventing complications. Multidisciplinary: dermatology, podiatry, pain specialists.

Mechanical Debridement

Regular podiatrist-performed paring/grinding of calluses/nails essential. Avoid over-thinning to prevent blistering.

Topical Therapies

• Keratolytics: Urea (20-40%), salicylic acid (6-40%) soften hyperkeratosis; limited efficacy.
• Moisturizers: Emollients (petrolatum) reduce fissuring.
• Retinoids: Topical tretinoin thins calluses but irritates.

Systemic Therapies

• Oral retinoids (acitretin): Reduce thickness but increase pain/skin fragility; short courses.

Pain Management

• NSAIDs, opioids pre-activity.
• Botulinum toxin injections: Reduce sweating/pain (lasts 3-6 months).

Devices

Custom orthotics, padded insoles redistribute pressure. Severe cases: crutches/wheelchair.

Infection Control

Antifungals/bacterials for secondary issues.

Experimental

siRNA (targeting mutant keratin), topical rapamycin, mTOR inhibitors in trials. Botulinum, fluorouracil tested.

Outcome

Chronic, lifelong; plantar pain limits mobility/employment. Complications: secondary infection, disability. Early intervention improves function. Genetic counseling crucial (50% recurrence risk). Patient registries (pachyonychia.org) aid research.

Frequently Asked Questions

What is pachyonychia congenita?

A rare genetic disorder causing painful thick calluses on feet, deformed nails, and mouth plaques due to keratin gene mutations.

Is there a cure for PC?

No cure exists; treatments manage symptoms like pain and thickening.

How is PC inherited?

Autosomal dominant: one mutated gene copy from a parent suffices; 30% sporadic.

Does PC affect life expectancy?

No; it impacts quality of life via pain/mobility but not survival.

Can children with PC walk normally?

Often not; pain may require aids from toddlerhood.